Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Sopherion licensed from Zeneus exclusive North American development and commercialization rights to Myocet liposomal doxorubicin.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury